Last reviewed · How we verify

NCT05066425: SCOPE

Soluble Corn Fiber for Promoting Executive Function Study

Status unknown NA Last updated 4 October 2021
What this trial tests

NA trial testing Soluble Corn Fiber in Health in 40 participants. Status unknown.

Timeline
2 August 2021
Primary endpoint
31 December 2022
30 June 2023

Quick facts

Lead sponsorUniversity of Illinois at Urbana-Champaign
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeprevention
Enrollment40
Start date2 August 2021
Primary completion31 December 2022
Estimated completion30 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Urbana-Champaign

Who can join

Adults 45 to 75, any sex, with Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching aim of this study is to test the influence of daily consumption of a soluble corn fiber (SCF) known i.e., PROMITOR® Soluble Fibre™ for cognitive function among middle and older-aged adults.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of Soluble Corn Fiber Consumption on Executive Functions and Gut Microbiota in Middle to Older Age Adults: A Randomized Controlled Crossover Trial.
    Alvarado DA, Holthaus TA, Martell S, Southey NL, et al · · 2026 · PMID 41825740 · DOI 10.1016/j.tjnut.2026.101473

Verify or expand the search:

Other trials of Soluble Corn Fiber

Trials testing the same drug.

Other recruiting trials for Health

Currently open trials in the same condition.

Other University of Illinois at Urbana-Champaign trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05066425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing